Literature DB >> 16622032

Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer.

Caren J Chancey1, Kristen V Khanna, Jos F M L Seegers, Guang Wen Zhang, James Hildreth, Abigail Langan, Richard B Markham.   

Abstract

The vaginal and cervical epithelia provide an initial barrier to sexually acquired HIV-1 infection in women. To study the interactions between HIV-1-infected cells or cell-free HIV-1 and the reproductive epithelium, the transmission of HIV-1 by infected cells or cell-free virus across human cervical epithelial cells was examined using a Transwell culture system. Cell-associated HIV-1 was transmitted more efficiently than cell-free virus, and monocyte-associated virus was transmitted most efficiently. Abs to ICAM-1 added to the apical side of the epithelium blocked cell-mediated transepithelial HIV-1 transmission in vitro. When used in a previously described model of vaginal HIV-1 transmission in human PBL-SCID mice, anti-murine ICAM-1 Abs (0.4 microg/10 microl) also blocked vaginal transmission of cell-associated HIV-1 in vivo. To evaluate a candidate delivery system for the use of this Ab as an anti-HIV-1 microbicide, anti-ICAM single-chain variable fragment Abs secreted by transformed lactobacilli were evaluated for their protective efficacy in the Transwell model. Like the intact Ab and Fab derived from it, the single-chain variable fragment at a concentration of 6.7 microg/100 microl was able to reduce HIV-1 transmission by 70 +/- 5%. These data support the potential efficacy of an anti-ICAM Ab delivered by lactobacilli for use as an anti-HIV-1 microbicide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622032     DOI: 10.4049/jimmunol.176.9.5627

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

2.  Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers.

Authors:  Luca Vangelista; Massimiliano Secchi; Xiaowen Liu; Angela Bachi; Letong Jia; Qiang Xu; Paolo Lusso
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

Review 3.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Monoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model Systems.

Authors:  Janet Tai Guedon; Kun Luo; Hong Zhang; Richard B Markham
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

Review 5.  Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.

Authors:  Stefan Miladinov Kovachev
Journal:  Microb Ecol       Date:  2014-04-08       Impact factor: 4.552

6.  Finally, a macaque model for cell-associated SIV/HIV vaginal transmission.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

7.  Integrative expression system for delivery of antibody fragments by lactobacilli.

Authors:  M Cruz Martín; Neha Pant; Victor Ladero; Gökçe Günaydin; Kasper Krogh Andersen; Beatriz Alvarez; Noelia Martínez; Miguel A Alvarez; Lennart Hammarström; Harold Marcotte
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

Review 8.  Strategies for preventing mucosal cell-associated HIV transmission.

Authors:  Kevin J Whaley; Kenneth H Mayer
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

9.  The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.

Authors:  Massimiliano Secchi; Qiang Xu; Paolo Lusso; Luca Vangelista
Journal:  Protein Expr Purif       Date:  2009-06-30       Impact factor: 1.650

10.  Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules.

Authors:  Xiaowen Liu; Laurel A Lagenaur; Peter P Lee; Qiang Xu
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.